[ORGANIZATION]
Hypera Pharma
Featured in 4 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
246 clusters · 894 sources · last updated
Latest: Medical experts propose management system for GLP-1 obesity drugs
Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr
Semaglutide regulatory approvals and pricing in Brazil
6 clusters · 107 sources · last updated
Latest: Mantecorp launches Semavy semaglutide medication in Brazil
Brazil’s National Health Surveillance Agency (Anvisa) has expanded the domestic market for semaglutide, a medication used to treat type 2 diabetes and weight loss. Initially, Anvisa registered five new semaglutide inject
Global oil profit surge and Petrobras dominance
3 clusters · 12 sources · last updated
Latest: Petrobras accounts for over half of B3's top ten companies' profits
In the second quarter of 2026, major global oil companies experienced a significant surge in profits. Combined net profits for 15 analyzed firms rose 134% to US$ 85 billion, up from approximately US$ 36.3 billion in the
Also covered in
-
Pfizer oncology sales climb 9% after Seagen acquisition amid strong health‑sector outlook
[BUSINESS] · 2 sources ·